pocketful logo
Dishman Carbogen Amcis Ltd logo

Dishman Carbogen Amcis Ltd

NSE: DCAL BSE: 540701

₹158.05

(-1.42%)

Mon, 23 Mar 2026, 10:08 am

mtf coin illustrationMTF 5x

Dishman Carbogen Amcis Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    2487.36

  • Net Profit

    3.24

  • P/B

    0.59

  • Sector P/E

    31.86

  • P/E

    1036.19

  • EV/EBITDA

    11.20

  • Debt/Equity (Industry)

    0.23

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    12.90

  • RONW (Industry)

    12.30

  • ROE

    -0.32

  • ROCE

    2.20

  • Debt/Equity

    0.41

  • EPS (TTM)

    8.41

  • Dividend Yield

    0

  • Book Value

    405.97

  • Interest Cover

    1.23

Analysis

all

thumbs up icon

Pros

  • Dishman Carbogen Amcis's earnings growth is expected to exceed the low risk savings rate of 7.2%.
  • An improvement in Dishman Carbogen Amcis's performance (ROE) is expected over the next 3 years.
  • Dishman Carbogen Amcis's revenue growth is expected to exceed the India market average.
  • Dishman Carbogen Amcis is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Dishman Carbogen Amcis is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dishman Carbogen Amcis is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
  • No need to calculate the sustainability of Dishman Carbogen Amcis's dividends as it is not paying a notable one for India.
  • Dishman Carbogen Amcis is not paying a notable dividend for India, therefore no need to check if the payments are stable.
  • Dishman Carbogen Amcis's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Dishman Carbogen Amcis's dividend is below the markets top 25% of dividend payers in India (3.08%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters59.3259.3259.3259.3259.32
FII7.668.079.939.498.75
DII1.271.371.271.261.42
Public31.7531.2329.4729.9330.51
Government00000

Read More

Technical Analysis

RSI

30.37

MACD

-11.74

50 DMA

197.37

200 DMA

245.44

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic314.84254.49214.77194.14154.42133.7973.44
Fibonacci254.49231.43217.19194.14171.08156.84133.79
Camarilla191.66186.12180.59194.14169.53164.00158.46

Pivots Level: Classic

R3

+120.70

314.84

R2

+60.35

254.49

R1

+20.64

214.77

194.14
194.14
Pivot Point
LTP: 142.78

S1

-39.71

154.42

S2

-60.35

133.79

S3

-120.70

73.44

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    160.76

  • 20-EMA

    169.06

  • 30-EMA

    177.38

  • 50-EMA

    191.54

  • 100-EMA

    213.40

  • 200-EMA

    227.80

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
03 Feb 2026board-meetingsQuarterly Results
04 Nov 2025board-meetingsQuarterly Results
29 Aug 2025agm
23 Aug 2024agm
22 Aug 2023agm
22 Aug 2022agm
15 May 2021agm
16 Jan 2020buyback
12 Aug 2019dividendDividend - Rs 0.20 Per Share14 Sept 2019
15 May 2019dividend₹0.20 Dividend /Share14 Sept 2019

Read More

Peer Comparison

Dishman Carbogen Amcis Ltd logo

Dishman Carbogen Amcis Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Lupin Ltd logo

Lupin Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Dishman Carbogen Amcis Ltd About

Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organisation (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. The equity shares of Dishman Carbogen Amcis Limited are listed on National Stock Exchange of India Ltd.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2007

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.dishmangroup.com

Email icon

Email

grievance@dishmangroup.com

Phone icon

Phone

91-2717-400102/124

Location icon

Location

Dishman Corporate House, Iscon-Bopal Road Ambli, Ahmedabad, Gujarat, 380058

Read More

Dishman Carbogen Amcis Ltd Company History

YearHistory
2007
  • The company was originally incorporated as Carbogen Amcis (India) Limited.
2016
  • The Scheme of Arrangement and Amalgamation was sanctioned by the High Court of Gujarat.
2017
  • The company name was changed to Dishman Carbogen Amcis Limited.
2019
  • Dishman Carbogen Amcis Limited acquired Dishman Biotech Limited.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
CRONY VYAPAR PVT LTDBuy1115624299.1911 Dec 2024
CRONY VYAPAR PVT LTDSell1135435299.911 Dec 2024
CRONY VYAPAR PVT LTDBuy1331863277.8609 Dec 2024
CRONY VYAPAR PVT LTDSell1136974277.8209 Dec 2024
CRONY VYAPAR PVT LTDBuy870469276.3305 Mar 2024
CRONY VYAPAR PVT LTDSell856469276.7705 Mar 2024
CRONY VYAPAR PVT LTDSell867097268.4904 Mar 2024
CRONY VYAPAR PVT LTDBuy1024504267.804 Mar 2024
GRAVITON RESEARCH CAPITAL LLPBuy925470173.1228 Dec 2023
GRAVITON RESEARCH CAPITAL LLPSell925470173.0628 Dec 2023

Read More

Dishman Carbogen Amcis Ltd News

Dishman Carbogen Amcis Board Approves Rs 150 Cr NCDs

Board approves issuance of Non-Convertible Debentures aggregating up to Rs 150 crores through private placement with 10% coupon rate and secured backing.

18 Mar 2026

companies

Dishman Carbogen Amcis Board Meet on March 18, 2026

Dishman Carbogen Amcis Limited has scheduled a board meeting for March 18, 2026, to consider and approve fund raising through Non-Convertible Debentures via private placement.

15 Mar 2026

companies

Dishman Carbogen Amcis Clarifies Credit Rating Downgrade

Dishman Carbogen Amcis provides clarification on India Ratings' downgrade to A/A1 with negative outlook, highlighting improved net leverage from 3.92x to 3.18x and better EBITDA margins excluding new facilities.

23 Feb 2026

stocks

Dishman Carbogen Amcis Q3FY26 Results Mixed Performance

Dishman Carbogen Amcis reports consolidated revenue of ₹719.80 crores for Q3FY26, up from ₹682.34 crores YoY, but posts net loss of ₹12.97 crores against ₹4.63 crores profit in Q3FY25.

03 Feb 2026

co actions results

DCAL Allots ₹50 Crore Non-Convertible Debentures

Dishman Carbogen Amcis Limited successfully allotted 5,000 senior secured non-convertible debentures worth ₹50 crores through private placement with 3-year maturity period.

20 Jan 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800